What are the clinical presentation and management of ascending cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triad of Ascending Cholangitis

The classic triad of ascending cholangitis, known as Charcot's triad, consists of fever (with or without chills), right upper quadrant abdominal pain, and jaundice. 1, 2, 3

Clinical Presentation

Charcot's Triad (Classic Presentation)

The three cardinal features that define acute cholangitis are:

  • Fever and/or chills - the most common presenting symptom 1, 3
  • Right upper quadrant or epigastric abdominal pain 1, 3
  • Jaundice - indicating biliary obstruction 1, 3

A definitive diagnosis can be made even when not all components of Charcot's triad are present, provided laboratory data and imaging findings support evidence of inflammation and biliary obstruction. 3

Reynolds' Pentad (Severe Disease)

When cholangitis progresses to severe disease with septic shock, two additional features may appear:

  • Altered mental status/confusion 4
  • Hemodynamic instability/septic shock 4

This five-component presentation (Reynolds' pentad) indicates life-threatening disease requiring urgent intervention. 4

Diagnostic Workup

Laboratory Findings

Cholestatic liver biochemistry is the hallmark laboratory pattern, characterized by:

  • Elevated alkaline phosphatase (ALP) - most common biochemical abnormality 1, 5
  • Elevated γ-glutamyl transpeptidase (GGT) 1, 5
  • Elevated serum bilirubin (both direct and indirect) 5
  • Elevated AST and ALT (typically 2-3 times upper limit of normal) 1, 5
  • Elevated inflammatory markers (CRP, procalcitonin, lactate) in critically ill patients 5

Imaging Studies

Abdominal ultrasound should be the initial imaging modality to assess for biliary obstruction, though it may be normal in early disease. 1

For definitive diagnosis and characterization of biliary obstruction:

  • Abdominal triphasic CT is recommended as first-line diagnostic imaging to detect ductal dilation and intra-abdominal collections 5
  • Contrast-enhanced MRCP provides exact visualization, localization, and classification of biliary obstruction 5
  • ERCP may be both diagnostic and therapeutic, allowing for immediate biliary drainage 1

Management Algorithm

Immediate Medical Management

All patients require prompt initiation of:

  1. Intravenous fluid resuscitation 2, 6
  2. Broad-spectrum antibiotic therapy within 1 hour for septic patients, within 6 hours for less severe cases 1

For non-critically ill, immunocompetent patients: Amoxicillin/Clavulanate 2g/0.2g every 8 hours 5

For beta-lactam allergy: Eravacycline 1 mg/kg every 12 hours or Tigecycline 100 mg loading dose then 50 mg every 12 hours 5

For critically ill or immunocompromised patients: Piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g every 6 hours or 16g/2g by continuous infusion 5

Biliary Drainage Strategy

The timing and method of biliary drainage depends on disease severity:

Severe (Grade III) Cholangitis

  • Requires urgent biliary decompression (as soon as possible) 1, 3
  • Accompanied by organ dysfunction 3

Moderate (Grade II) Cholangitis

  • Requires early biliary drainage within 24 hours 1
  • Does not respond to initial medical treatment but without organ dysfunction 3
  • Early drainage (<24 hours) significantly reduces 30-day mortality 1

Mild (Grade I) Cholangitis

  • Can be initially observed on medical treatment 1, 3
  • Responds to initial medical therapy 3
  • Elective drainage can be performed after clinical stabilization 1

Drainage Modality Selection

Endoscopic transpapillary biliary drainage (ERCP with stent placement) is the first-line procedure for biliary decompression, as it is safer and more effective than percutaneous or surgical approaches. 1, 4

The focus in severe biliary sepsis should be on biliary decompression rather than definitive treatment, with minimal manipulation of the biliary tree. 1

Percutaneous transhepatic biliary drainage (PTBD) should be reserved for cases where endoscopic approaches fail or are not feasible. 1

Open surgical drainage is currently extremely rare due to widespread availability of endoscopic and percutaneous techniques. 1

Common Pitfalls

Do not delay biliary drainage in moderate or severe cholangitis - antibiotics alone are insufficient when biliary obstruction persists, as cholangitis cannot occur without obstruction. 1

Recognize that episodes of cholangitis are uncommon at initial presentation of PSC unless there has been prior biliary surgery or instrumentation. 1 This helps distinguish primary from secondary sclerosing cholangitis.

Be aware that not all patients present with complete Charcot's triad - diagnosis can still be made with supporting laboratory and imaging findings. 3

After resolution of sepsis, definitive treatment of the underlying cause (such as choledocholithiasis, strictures, or malignancy) is necessary to prevent recurrence. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Cholangitis: Causes, Diagnosis, and Management.

Gastroenterology clinics of North America, 2021

Research

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.

Journal of hepato-biliary-pancreatic surgery, 2007

Research

Acute Bacterial Cholangitis.

Viszeralmedizin, 2015

Guideline

Ascending Cholangitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute cholangitis - an update.

World journal of gastrointestinal pathophysiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.